Literature DB >> 23536430

The VPS35 gene and Parkinson's disease.

Hao Deng1, Kai Gao, Joseph Jankovic.   

Abstract

Parkinson's disease (PD), the second most common age-related neurodegenerative disease, is characterized by loss of dopaminergic and nondopaminergic neurons, leading to a variety of motor and nonmotor symptoms. In addition to environmental factors, genetic predisposition and specific gene mutations have been shown to play an important role in the pathogenesis of this disorder. Recently, the identification of the vacuolar protein sorting 35 homolog gene (VPS35), linked to autosomal dominant late-onset PD, has provided new clues to the pathogenesis of PD. Here we discuss the VPS35 gene, its protein function, and various pathways involved in Wnt/β-catenin signaling and in the role of DMT1 mediating the uptake of iron and iron translocation from endosomes to the cytoplasm. Further understanding of these mechanisms will undoubtedly provide new insights into the pathogenic mechanisms of PD and may lead to prevention and better treatment of the disorder.
Copyright © 2013 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23536430     DOI: 10.1002/mds.25430

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  35 in total

1.  DNA and RNA sequencing identified a novel oncogene VPS35 in liver hepatocellular carcinoma.

Authors:  Guiji Zhang; Xia Tang; Li Liang; Wanfeng Zhang; Dewei Li; Xiaoyuan Li; Dachun Zhao; Yaqiu Zheng; Yanhong Chen; Bingtao Hao; Kai Wang; Ni Tang; Keyue Ding
Journal:  Oncogene       Date:  2020-02-19       Impact factor: 9.867

Review 2.  Animal models of Parkinson's disease: a gateway to therapeutics?

Authors:  Weidong Le; Pavani Sayana; Joseph Jankovic
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 3.  A Review on Response to Device-Aided Therapies Used in Monogenic Parkinsonism and GBA Variants Carriers: A Need for Guidelines and Comparative Studies.

Authors:  Philippe A Salles; James Liao; Umar Shuaib; Ignacio F Mata; Hubert H Fernandez
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

4.  Mechanisms of VPS35-Mediated Neurodegeneration in Parkinson's Disease.

Authors:  Dorian Sargent; Darren J Moore
Journal:  Int Rev Mov Disord       Date:  2021-09-30

Review 5.  Role of Nrf2 in Parkinson's Disease: Toward New Perspectives.

Authors:  Xin-Xing Yang; Rong Yang; Feng Zhang
Journal:  Front Pharmacol       Date:  2022-06-24       Impact factor: 5.988

Review 6.  Genetic convergence of Parkinson's disease and lysosomal storage disorders.

Authors:  Hao Deng; Xiaofei Xiu; Joseph Jankovic
Journal:  Mol Neurobiol       Date:  2014-08-07       Impact factor: 5.590

Review 7.  Endosomal sorting pathways in the pathogenesis of Parkinson's disease.

Authors:  Lindsey A Cunningham; Darren J Moore
Journal:  Prog Brain Res       Date:  2020-03-16       Impact factor: 2.453

8.  Genetic association of sirtuin genes and Parkinson's disease.

Authors:  Silvia Jesús; Pilar Gómez-Garre; Fátima Carrillo; María T Cáceres-Redondo; Ismael Huertas-Fernández; Inmaculada Bernal-Bernal; Marta Bonilla-Toribio; Laura Vargas-González; Manuel Carballo; Pablo Mir
Journal:  J Neurol       Date:  2013-05-30       Impact factor: 4.849

9.  VPS35 D620N knockin mice recapitulate cardinal features of Parkinson's disease.

Authors:  Mengyue Niu; Fanpeng Zhao; Karina Bondelid; Sandra L Siedlak; Sandy Torres; Hisashi Fujioka; Wenzhang Wang; Jun Liu; Xiongwei Zhu
Journal:  Aging Cell       Date:  2021-03-21       Impact factor: 9.304

Review 10.  Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.

Authors:  Francesca L'Episcopo; Cataldo Tirolo; Salvo Caniglia; Nuccio Testa; Maria Concetta Morale; Maria Francesca Serapide; Stefano Pluchino; Bianca Marchetti
Journal:  J Mol Cell Biol       Date:  2014-01-14       Impact factor: 6.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.